The FSMA appears to be a major undertaking with a very large responsibility placed on the FDA. It would seem that bottlenecks to exporting are bound to appear which will be very frustrating for Canadian firms. It is important for Canadian firms and Canadian policy makers to work hard to ensure...

Until there is a successful challenge at the WTO, the EU policy on LLP is likely to remain in place. Under this policy, there is a zero tolerance level for GM material that has not received EU authorization. Zero tolerance, however, has to be operationalized – what does an exporting country...

Public policy makers in Canada should expect the US to object to the extension of protection to EU GIs in the CETA. The expected gains made in other areas of the CETA for agreeing to protect EU GIs need to be weighed carefully against the potential cost of trade actions through NAFTA. The NAFTA...